TL;DR: The Centers for Medicare & Medicaid Services modified NCD 184 governing diagnostic Pap smear coverage under Medicare Part B, effective March 7, 2026. Here's what billing teams need to do.
CMS updated NCD 184 — the National Coverage Determination governing Medicare Part B coverage of diagnostic Pap smears — with a March 7, 2026 effective date. The policy does not list specific CPT or HCPCS codes in this version, which creates a documentation burden your billing team needs to address now. If your practice bills diagnostic gynecologic services to Medicare, the medical necessity criteria in this policy directly govern your reimbursement and your exposure to claim denial.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Diagnostic Pap Smears |
| Policy Code | NCD 184 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | OB/GYN, Primary Care, Women's Health, Oncology |
| Key Action | Audit diagnostic Pap smear claims to confirm documentation maps to one of the five covered indications before March 7, 2026 |
CMS Diagnostic Pap Smear Coverage Criteria and Medical Necessity Requirements 2026
The core of this coverage policy is a five-condition framework. A diagnostic Pap smear — and related medically necessary services — is covered under Medicare Part B when a physician orders it under at least one of these indications:
| # | Covered Indication |
|---|---|
| 1 | Previous cancer of the cervix, uterus, or vagina that has been or is presently being treated |
| 2 | Previous abnormal Pap smear |
| 3 | Any abnormal findings of the vagina, cervix, uterus, ovaries, or adnexa |
| 4 | Any significant complaint by the patient referable to the female reproductive system |
| 5 | Any signs or symptoms that the physician's judgment reasonably relates to a gynecologic disorder |
The last two criteria are where most claim denials originate. "Significant complaint" and "signs or symptoms in the physician's judgment" are inherently subjective — CMS is placing the documentation burden squarely on the ordering physician. If the chart doesn't articulate the clinical rationale that maps the visit to one of these five buckets, you're billing a service that looks unsubstantiated to a payer reviewer.
The real issue here is that this policy sits under Medicare Part B's Diagnostic Laboratory Tests benefit category. That means prior authorization isn't the primary risk — insufficient medical necessity documentation is. Denials on these claims typically come post-adjudication, during audit or review, not at the front door. That makes them harder to catch and more expensive to appeal.
This policy references and cross-links to NCD 210.2, which governs screening Pap smears and pelvic examinations for early detection of cervical or vaginal cancer. The distinction matters enormously for billing. A screening Pap smear on a low-risk, asymptomatic Medicare patient is covered under different authority and different rules. Billing a service under NCD 184 when it should be billed as a screening — or vice versa — is a path to denied claims and potential overpayment liability. Know which policy applies before the claim goes out.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Previous cancer of the cervix, uterus, or vagina (treated or currently being treated) | Covered | Not specified in policy | Physician order required; document treatment history in chart |
| Previous abnormal Pap smear | Covered | Not specified in policy | Prior result must be documented; link clinical history in the record |
| Abnormal findings of the vagina, cervix, uterus, ovaries, or adnexa | Covered | Not specified in policy | Findings must be documented by the ordering physician |
| Significant complaint by the patient referable to the female reproductive system | Covered | Not specified in policy | Complaint must be explicitly documented; "patient reported" alone is insufficient |
| Signs or symptoms reasonably related to a gynecologic disorder (physician's judgment) | Covered | Not specified in policy | Physician must document clinical rationale; this is a judgment-based criterion |
| Screening Pap smear for asymptomatic patients | Not covered under NCD 184 | See NCD 210.2 | Covered under separate screening benefit — do not bill under NCD 184 |
CMS Diagnostic Pap Smear Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Audit your current diagnostic Pap smear claims before March 7, 2026. Pull claims from the last 90 days and confirm each one maps explicitly to one of the five covered indications. If you're finding claims with thin documentation, that's your denial risk inventory. |
| 2 | Confirm your providers understand the diagnostic vs. screening distinction. This is not a documentation technicality — it's a coverage policy boundary. Screening Pap smears fall under NCD 210.2, not NCD 184. If a provider orders a diagnostic Pap on a patient who qualifies only for screening, you're billing under the wrong authority and the claim is vulnerable. |
| 3 | Update your encounter templates or EHR documentation prompts to capture all five indication criteria. The physician must do more than check a box. The chart note needs to articulate why the service is diagnostic — whether that's a prior abnormal result, a patient-reported complaint, or clinical findings from the exam. If the documentation doesn't say it, the payer won't assume it. |
| 4 | Brief your coders on the lack of specific codes in this version of NCD 184. The policy does not enumerate CPT or HCPCS codes. That means your team is responsible for applying the correct procedure codes based on what was actually performed and ensuring the medical necessity documentation supports the diagnostic — not screening — classification. Talk to your billing consultant if your charge capture process doesn't have a clear decision point for this distinction. |
| 5 | Flag any accounts with gynecologic oncology history for closer review. Patients with previous cervical, uterine, or vaginal cancer are explicitly covered under criterion one — but "has been or is presently being treated" requires that treatment history to be documented and accessible. A patient five years out from cervical cancer treatment still qualifies, but only if the record reflects it. |
| 6 | If your practice straddles diagnostic and screening services for the same patient in the same encounter, loop in your compliance officer. Billing both NCD 184 and NCD 210.2 services in a single encounter isn't inherently wrong, but it requires precise documentation and code selection. Get eyes on this before the March 7, 2026 effective date if it's part of your standard workflow. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Diagnostic Pap Smears Under NCD 184
NCD 184 as modified does not list specific CPT, HCPCS, or ICD-10 codes. This is not uncommon for CMS National Coverage Determinations — the NCD establishes the coverage framework and indications, while code-level billing guidance typically appears in Local Coverage Determinations (LCDs), Local Coverage Articles (LCAs), or claims processing instructions issued by the Medicare Administrative Contractors (MACs).
Your next step is to check with your MAC for the applicable billing codes and any contractor-specific guidance tied to NCD 184. The Palmetto GBA, Noridian, CGS, Novitas, and other MACs publish article-level guidance that bridges the gap between an NCD's clinical criteria and the specific codes your billing team needs on the claim.
Do not fabricate or assume codes based on this policy alone. The absence of enumerated codes in NCD 184 means your MAC's guidance is authoritative for your region — and billing the wrong procedure code, even against a legitimate diagnosis, is a denial waiting to happen.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.